ATAlberto Torresin

Alberto Torresin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alberto Torresin has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The history and contributions of the EFOMP science committee: an overview

    by J.C. Dickson, E. Boman, R.A. Amos, L. Marcu, A. Torresin

  • Open Access

    Optimising strategies for artificial intelligence-assisted classification of viral pneumonias on CT imaging: a comparative study of selective and default approaches

    by Francesco Rizzetto, Luca Berta, Giulia Zorzi, Francesca Travaglini, Diana Artioli, Luca Alessandro Carbonaro, Silvia Nerini Molteni, Chiara Vismara, Alberto Torresin, Paola Enrica Colombo, et al.

    Purpose: To evaluate how different artificial intelligence (AI)-powered approaches affect human performance in a demanding chest computed tomography (CT) task, such as distinguishing between viral pneumonias.Material and methods: Three radiologists blindly evaluated 220 chest CT scans of viral pneumonia cases (n = 151 COVID-19; n = 69 other viruses), classifying them with a probabilistic scoring system (COVID-19 Reporting and Data System – CO-RADS) in 2 phases: before (S1) and after (S2) receiving AI classifier results. Two S2 scenarios were investigated: a default approach, with AI predictions available for all cases, and a selective approach, with AI limited to equivocal S1 cases (CO-RADS = 3). Inter-reader agreement (Gwet’s AC2) and diagnostic performance were analysed.Results: Radiologists demonstrated good-to-excellent agreement across all scenarios (AC2 = 0.77-0.81). Evaluation changes between S1 and S2 occurred in 18% of cases, with 29% of cases initially classified as CO-RADS = 3. In these equivocal cases, AI led to an average correct classification rate of 85%. Conversely, when radiologists were confident in their S1 diagnoses (CO-RADS ≠ 3), classification changes in S2 occurred in 7% of cases, preventing incorrect diagnoses in 45% of patients but resulting in missed correct classifications in 55%. Regarding diagnostic performance, S1 accuracy was 78%, with 15% of CO-RADS = 3 cases. In S2, under the default approach, accuracy increased to 81%, with 16% of CO-RADS = 3 cases, whereas the selective approach achieved 79% accuracy with only 10% of CO-RADS = 3 cases. Only the selective approach significantly reduced the proportion of equivocal cases (p < 0.009).Conclusions: A selective AI approach effectively reduces diagnostic uncertainty without introducing unnecessary complexity, emphasising its potential to optimise radiological workflows in challenging diagnostic scenarios.

  • Radiomic features analysis to automatically predict COVID-19 severity outcome by using the LungQuant segmentation software: a multi-center study

    by Camilla Scapicchio, Elena Ballante, Alida Benfante, Luca Berta, Chandra Bortolotto, Francesca Brero, Raffaella Fiamma Cabini, Andrea Chincarini, Davide Cicolari, Paola Enrica Colombo, et al.

    **Abstract text** Background: COVID-19 disease is a public health problem worldwide. Different studies proved that Computed Tomography (CT) bring | POSTER

  • Open Access

    Diagnostic Performance in Differentiating COVID-19 from Other Viral Pneumonias on CT Imaging: Multi-Reader Analysis Compared with an Artificial Intelligence-Based Model

    by Francesco Rizzetto, Luca Berta, Giulia Zorzi, Antonino Cincotta, Francesca Travaglini, Diana Artioli, Silvia Nerini Molteni, Chiara Vismara, Francesco Scaglione, Alberto Torresin, et al.

    Growing evidence suggests that artificial intelligence tools could help radiologists in differentiating COVID-19 pneumonia from other types of viral (non-COVID-19) pneumonia. To test this hypothesis, an R-AI classifier capable of discriminating between COVID-19 and non-COVID-19 pneumonia was developed using CT chest scans of 1031 patients with positive swab for SARS-CoV-2 (n = 647) and other respiratory viruses (n = 384). The model was trained with 811 CT scans, while 220 CT scans (n = 151 COVID-19; n = 69 non-COVID-19) were used for independent validation. Four readers were enrolled to blindly evaluate the validation dataset using the CO-RADS score. A pandemic-like high suspicion scenario (CO-RADS 3 considered as COVID-19) and a low suspicion scenario (CO-RADS 3 considered as non-COVID-19) were simulated. Inter-reader agreement and performance metrics were calculated for human readers and R-AI classifier. The readers showed good agreement in assigning CO-RADS score (Gwet’s AC2 = 0.71, p < 0.001). Considering human performance, accuracy = 78% and accuracy = 74% were obtained in the high and low suspicion scenarios, respectively, while the AI classifier achieved accuracy = 79% in distinguishing COVID-19 from non-COVID-19 pneumonia on the independent validation dataset. The R-AI classifier performance was equivalent or superior to human readers in all comparisons. Therefore, a R-AI classifier may support human readers in the difficult task of distinguishing COVID-19 from other types of viral pneumonia on CT imaging.


  • Open Access

    Statement of the Italian Association of Medical Physics (AIFM) task group on radiation dose monitoring systems

    by Francesco Ria, Loredana D’ercole, Daniela Origgi, Nicoletta Paruccini, Luisa Pierotti, Osvaldo Rampado, Veronica Rossetti, Sabina Strocchi, Alberto Torresin

    The evaluation of radiation burden in vivo is crucial in modern radiology as stated also in the European Directive 2013/59/Euratom—Basic Safety Standard. Although radiation dose monitoring can impact the justification and optimization of radiological procedure, as well as effective patient communication, standardization of radiation monitoring software is far to be achieved. Toward this goal, the Italian Association of Medical Physics (AIFM) published a report describing the state of the art and standard guidelines in radiation dose monitoring system quality assurance. This article reports the AIFM statement about radiation dose monitoring systems (RDMSs) summarizing the different critical points of the systems related to Medical Physicist Expert (MPE) activities before, during, and after their clinical implementation. In particular, the article describes the general aspects of radiation dose data management, radiation dose monitoring systems, data integrity, and data responsibilities. Furthermore, the acceptance tests that need to be implemented and the most relevant dosimetric data for each radiological modalities are reported under the MPE responsibility.


  • A method for T1 and T2 relaxation times validation and harmonization as a support to MRI mapping

    by Davide Cicolari, Domenico Lizio, Patrizia Pedrotti, Monica Teresa Moioli, Alessandro Lascialfari, Manuel Mariani, Alberto Torresin


  • Automatic lung segmentation in COVID-19 patients: Impact on quantitative computed tomography analysis

    by L. Berta, F. Rizzetto, C. De Mattia, D. Lizio, M. Felisi, P.E. Colombo, S. Carrazza, S. Gelmini, L. Bianchi, D. Artioli, et al.


  • Open Access

    Correlation between lung ultrasound and chest CT patterns with estimation of pulmonary burden in COVID-19 patients

    by Francesco Rizzetto, Noemi Perillo, Diana Artioli, Francesca Travaglini, Alessandra Cuccia, Stefania Zannoni, Valeria Tombini, Sandro Luigi Di Domenico, Valentina Albertini, Marta Bergamaschi, et al.


  • Open Access

    Estimation of patient skin dose in fluoroscopy: summary of a joint report by AAPM TG357 and EFOMP

    by Jonas Andersson, Daniel R. Bednarek, Wesley Bolch, Thomas Boltz, Hilde Bosmans, Amber J. Gislason‐Lee, Christoffer Granberg, Max Hellstrom, Kalpana Kanal, Ed McDonagh, et al.

    Background: Physicians use fixed C‐arm fluoroscopy equipment with many interventional radiological and cardiological procedures. The associated effective dose to a patient is generally considered low risk, as the benefit‐risk ratio is almost certainly highly favorable. However, X‐ray‐induced skin injuries may occur due to high absorbed patient skin doses from complex fluoroscopically guided interventions (FGI). Suitable action levels for patient‐specific follow‐up could improve the clinical practice.There is a need for a refined metric regarding follow‐up of X‐ray‐induced patient injuries and the knowledge gap regarding skin dose‐related patient information from fluoroscopy devices must be filled. The most useful metric to indicate a risk of erythema, epilation or greater skin injury that also includes actionable information is the peak skin dose, that is, the largest dose to a region of skin.Materials and Methods: The report is based on a comprehensive review of best practices and methods to estimate peak skin dose found in the scientific literature and situates the importance of the Digital Imaging and Communication in Medicine (DICOM) standard detailing pertinent information contained in the Radiation Dose Structured Report (RDSR) and DICOM image headers for FGI devices. Furthermore, the expertise of the task group members and consultants have been used to bridge and discuss different methods and associated available DICOM information for peak skin dose estimation.Results: The report contributes an extensive summary and discussion of the current state of the art in estimating peak skin dose with FGI procedures with regard to methodology and DICOM information. Improvements in skin dose estimation efforts with more refined DICOM information are suggested and discussed.Conclusions: The endeavor of skin dose estimation is greatly aided by the continuing efforts of the scientific medical physics community, the numerous technology enhancements, the dose‐controlling features provided by the FGI device manufacturers, and the emergence and greater availability of the DICOM RDSR. Refined and new dosimetry systems continue to evolve and form the infrastructure for further improvements in accuracy. Dose‐related content and information systems capable of handling big data are emerging for patient dose monitoring and quality assurance tools for large‐scale multihospital enterprises.